Cargando…

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations

Detalles Bibliográficos
Autores principales:	Bruno, William, Martinuzzi, Claudia, Dalmasso, Bruna, Andreotti, Virginia, Pastorino, Lorenza, Cabiddu, Francesco, Gualco, Marina, Spagnolo, Francesco, Ballestrero, Alberto, Queirolo, Paola, Grillo, Federica, Mastracci, Luca, Ghiorzo, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033371/ https://www.ncbi.nlm.nih.gov/pubmed/29983899 http://dx.doi.org/10.18632/oncotarget.25684

Ejemplares similares

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2017)

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry
por: Bruno, William, et al.
Publicado: (2016)

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020)

Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients
por: Ciccarese, Giulia, et al.
Publicado: (2020)

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
por: Vanni, Irene, et al.
Publicado: (2023)

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
por: Spagnolo, Francesco, et al.
Publicado: (2015)

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
por: Spagnolo, Francesco, et al.
Publicado: (2014)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
por: Pastorino, Lorenza, et al.
Publicado: (2020)

Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development
por: Bruno, William, et al.
Publicado: (2017)

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
por: Puccini, Alberto, et al.
Publicado: (2022)

Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer
por: Dalmasso, Bruna, et al.
Publicado: (2023)

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms
por: Pastorino, Lorenza, et al.
Publicado: (2021)

Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges
por: Pastorino, Lorenza, et al.
Publicado: (2023)

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
por: Vanni, Irene, et al.
Publicado: (2020)

Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
por: Bruno, W., et al.
Publicado: (2022)

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
por: Vanni, Irene, et al.
Publicado: (2020)

Current State of Target Treatment in BRAF Mutated Melanoma
por: Tanda, Enrica Teresa, et al.
Publicado: (2020)

Germline and somatic drivers in inherited hematologic malignancies
por: Zoller, Julian, et al.
Publicado: (2023)

TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear
por: Monti, Paola, et al.
Publicado: (2017)

Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function
por: Manzini, Claudia, et al.
Publicado: (2016)

Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment
por: Konnick, Eric Q., et al.
Publicado: (2016)

Identification, genetic testing, and management of hereditary melanoma
por: Leachman, Sancy A., et al.
Publicado: (2017)

Identification of Driver Epistatic Gene Pairs Combining Germline and Somatic Mutations in Cancer
por: Rocha, Jairo, et al.
Publicado: (2023)

Germline competent mesoderm: the substrate for vertebrate germline and somatic stem cells?
por: Savage, Aaron M., et al.
Publicado: (2021)

Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients
por: Dalmasso, Bruna, et al.
Publicado: (2022)

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer
por: Coco, Simona, et al.
Publicado: (2019)

Joint genotype inference with germline and somatic mutations
por: Bareke, Eric, et al.
Publicado: (2013)

Mediation of organismal aging and somatic proteostasis by the germline
por: Khodakarami, Amirabbas, et al.
Publicado: (2015)

Genetic and Chemical Effects on Somatic and Germline Aging
por: Lee, Myon-Hee, et al.
Publicado: (2020)

Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG
por: Giannareas, Nikolaos, et al.
Publicado: (2022)

Immunohistochemical correlates of TP53 somatic mutations in cancer
por: Murnyák, Balázs, et al.
Publicado: (2016)

One Cell, Two Gears: Extensive Somatic Genome Plasticity Accompanies High Germline Genome Stability in Paramecium
por: Catania, Francesco, et al.
Publicado: (2021)

Germline Variation Controls the Architecture of Somatic Alterations in Tumors
por: Dworkin, Amy M., et al.
Publicado: (2010)

Integrated Analysis of Germline and Somatic Variants in Ovarian Cancer
por: Kanchi, Krishna L., et al.
Publicado: (2014)

Germline and somatic mtDNA mutations in mouse aging
por: Ma, Hong, et al.
Publicado: (2018)

RASopathies: From germline mutations to somatic and multigenic diseases
por: Riller, Quentin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ddjaniitslbln8g3egnmi2kvbt